Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Inversago Pharma logo — Pioneering innovative therapies to enhance the lives of pati...

Inversago Pharma

Pioneering innovative therapies to enhance the lives of patients with metabolic and fibrotic conditions.

Founded 2015 Series C Total: $137.00M Biopharma, Biotechnology +2

General Information

Company Name Inversago Pharma
Founded Year 2015
Founders / Decision Makers
Team member Team member
Industries Biopharma, Biotechnology, Health Care +1
Funding Stage Series C
Social

Get notified when Inversago Pharma moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Inversago Pharma

Inversago Pharma is a Montreal-based biotech company, founded in 2015, that focuses on developing innovative therapies for patients with metabolic and fibrotic conditions. Specializing in CB1 blockade through peripherally-acting, CB1 inverse agonists, the company aims to enhance treatment options for a range of conditions including Diabetic Kidney Disease (DKD), Diabetic Nephropathy (DN), Type 1 and Type 2 Diabetes (T1D/T2D), Non-Alcoholic Steatohepatitis (NASH), obesity-related complications, hypertriglyceridemia (HTG), and fibrotic conditions such as Progressive Fibrosis - Interstitial Lung Disease (PF-ILD) and Idiopathic Pulmonary Fibrosis (IPF). Inversago Pharma recently received a $95.00M Series C investment on 17 October 2022 from notable investors including New Enterprise Associates, Amgen Ventures, T1D Fund, Forbion, adMare BioInnovations, Amorchem, Genesys Capital Management Inc, Fonds de solidarité FTQ. With a focus on pioneering therapies, the company aims to significantly impact the lives of patients in need of new treatment options for complex medical conditions.

Taxonomy: biotech company, clinical-stage, therapies, metabolic conditions, fibrotic conditions, CB1 blockade, inverse agonists, Diabetic Kidney Disease, Diabetic Nephropathy, Type 1 Diabetes, Type 2 Diabetes, Non-Alcoholic Steatohepatitis, obesity-related complications, hypertriglyceridemia, Progressive Fibrosis

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series C •••••• 8
Investor Investor Investor Investor Investor Investor Investor
•••• •••• 		17 Oct 2022
Series B •••••• 2
Investor
•••• •••• 		08 Sep 2020
Series A •••••• - 25 Jul 2018

Inversago Pharma Alternatives & Competitors

Inversago Pharma vs
DiObex
DiObex

Innovative biotechnology solutions for metabolic disorders.

Series B
Biotechnology, Health Care
Inversago Pharma vs
Otida
Otida Egypt

A HealthTech company offering an innovative and efficient care model for diabetic patients. We aim a...

Pre Seed
8 employees
Health Care, Health and Wellness
Inversago Pharma vs
TIGAR Health
TIGAR Health United States

Transforming Metabolic Medicine

5 employees
Health Care, Information Technology

FAQ About Inversago Pharma

Pioneering innovative therapies to enhance the lives of patients with metabolic and fibrotic conditions.
Inversago Pharma was founded in 2015.
Inversago Pharma operates in the following industries: Biopharma, Biotechnology, Health Care, Pharmaceutical.
Inversago Pharma has completed 3 funding rounds, raising a total of $137.00M. The latest funding stage is Series C.
Top alternatives and competitors to Inversago Pharma include DiObex, Otida, TIGAR Health, Diabetic & Me, Lucas Research. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Inversago Pharma and DiObex are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Inversago Pharma and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy